8 insiders reported 10 Form 4 transactions for Eledon Pharmaceuticals, Inc. (ELDN) over the past 18 months (most recent 2026-08-04). Recent activity: Gros David-Alexandre C (Chief Executive Officer) Buy 354,454 shares, Perrin Steven (President) Buy 152,353 shares, Gros David-Alexandre C (Chief Executive Officer) Sell 194,791 shares, Perrin Steven (President) Sell 72,138 shares, Katkin Keith (Director) Buy 8,575 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Gros David-Alexandre C | Chief Executive Officer | Buy | 354,454 | $0 |
| 2026-08-04 | Perrin Steven | President | Buy | 152,353 | $0 |
| 2026-08-04 | Gros David-Alexandre C | Chief Executive Officer | Sell | 194,791 | $658,394 |
| 2026-08-04 | Perrin Steven | President | Sell | 72,138 | $243,826 |
| 2026-01-16 | Katkin Keith | Director | Buy | 8,575 | $0 |
| 2026-01-16 | Lee June | Director | Buy | 3,430 | $0 |
| 2026-01-16 | Robinson James A. Jr. | Director | Buy | 3,430 | $0 |
| 2026-01-16 | Kirk Allan | Director | Buy | 3,430 | $0 |
| 2026-01-16 | Hillson Jan | Director | Buy | 3,430 | $0 |
| 2026-01-16 | McBride John S. | Director | Buy | 3,430 | $0 |
Source: SEC Form 4 filings · as of 2026-08-04